First‐In‐Human Safety, Pharmacokinetics, and Pharmacodynamics of VENT‐02 Freebase, a CNS‐Penetrant NLRP3 Inhibitor.
Saved in:
| Title: | First‐In‐Human Safety, Pharmacokinetics, and Pharmacodynamics of VENT‐02 Freebase, a CNS‐Penetrant NLRP3 Inhibitor. |
|---|---|
| Authors: | Smidt, Lisanne C. A.1,2 (AUTHOR), Moerland, Matthijs1,2 (AUTHOR), Jansen, Manon A. A.1,2 (AUTHOR), Kremer, Philip H. C.1,2 (AUTHOR), Sille, Alexandra A. J.1,2 (AUTHOR), Strugala, Pamela K.1 (AUTHOR), Klaassen, Erica S.1 (AUTHOR), Auger, Anick3 (AUTHOR), Jananji, Silvana3 (AUTHOR), Faidi, Rania3 (AUTHOR), Pike, Kelly A.3 (AUTHOR), Warner, Loraine4 (AUTHOR), Matta, Andre4 (AUTHOR), Valencia, Xavier4 (AUTHOR), Spiegelstein, Ofer4 (AUTHOR) ospiegelstein@gmail.com |
| Source: | CTS: Clinical & Translational Science. May2026, Vol. 19 Issue 5, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17528054 |
|---|---|
| DOI: | 10.1111/cts.70578 |